PENGARUH KONSUMSI OBAT OLEH IBU HAMIL TERHADAP JANIN YANG DIKANDUNG
PENGARUH KONSUMSI OBAT OLEH IBU HAMIL TERHADAP JANIN YANG DIKANDUNG
Embedded Files
Important Announcement: Journal status update, Garuda indexation, and the separation of OJS systems.
Lina Winarti
Bagian Farmasetika Program Studi Farmasi Universitas Jember
Budipratiwi Wisudyaningsih
Bagian Farmasetika Program Studi Farmasi Universitas Jember
DOI:
Keywords:
ABSTRACT
Pregnant woman is possible to expose with disease which need to cure by using drugs. Sometimes a woman suffer from chronic disease should take some medicine, even in pregnant condition. Risk of harm effect happened on consuming drug at pregnant condition depend on type & when the drug given. In first two week, growth of fetus embryo is known by the most critical effect of teratogenic defect because of drug administration. Most critical period of growth of embryo started about 17 day of post impregnation when system organ expanding. It is last until 60 -70 days. Administration of certain drugs on that period can give teratogenic effect. Administration of drug on pregnant woman should be carried with extra attention, because of the possible risk that can occur during a period of pregnancy. If pregnant woman can’t avoid not taking drug therapy, she has to counsel with physician to decide what kind of drug she should take. On the other side, before giving drug therapy physician has to consider about drug safety, dosage, usage duration, type of drug & way the drug should given.
REFERENCES
Anonim, 2006, Appendix: 4 Pregnancy, British National Formulary, edisi 52, BMJ Publishing Group Ltd and RPS Publishing
Behrman, E.R., and Vaughan, C.V., 1983, The Fetus and the New Born Infant, In Nelson, W.E., (Ed.), Nelson; The Text Book of Pediatrics, 35-39, W.B., Saunders Company, Philadelpia
Crowter, C. and Henry, A. 2000. The MAP Study: Patterns of Medication Use during and Prior to Pregnancy. Aust NZ.J Obstet Gynaecol
E-Stine, Brown, T.M., 1996, Principles of Toxicology, 80-81, CRC Lewis Publisher, New York
Jawi, L.Made, 1999, Pertimbangan Praktis Penggunaan Obat pada Wanita Hamil, Dexa Media Informasi untuk Masyarakat Kedokteran dan Farmasi, 12, 4, 26-28
Koren, G., Pastuszak, A., Ito, S., 1998, Drugs In Pregnancy, The New England Journal of Medicine No. 16, Massachusetts Medicinal Society Publishing
Loomis, I.A., 1978, Essentiale of Toxicology, diterjemahkan oleh Imono, A.D., Edisi III, 242-248, IKIP Semarang Press, Semarang
Siswosudarmo, R., 1995, Perkembangan Janin, dalam Sri Suryawati (Ed.), Efek Samping Obat, edisi kedua, 219-223, Pusat Studi Farmakologi Klinik dan Kebijakan Obat Universitas Gadjah Mada, Yogyakarta
Tuchmann-Duplessis, H., 1976, Embryonic Clinical Pharmacology, In G.S. Avery (Ed.), Drug Treatment Principles and Practice of Clinical Pharmacology and Therapeutics, 2nd Ed, 43-55, Adis Press, Sydney
Page updated
Report abuse